MAY 16, 2020 11:07 AM PDT

Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection

WRITTEN BY: Amanda Mikyska

Jeffery Schweitzer, MD, PhD and lead author of the study elaborates on the research methods and hopes for stem cell technology in the future. 

 

Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that avoids rejection by the patient's body, a significant limitation of stem cell therapy.  The experiment was only conducted in one Parkinson's patient, but researchers hope the results will open the door for a larger sample size.  

Stem cells have not "differentiated," meaning they have not taken the form of a specific cell type, such as a skin cell or a nerve cell.  Stem cells give rise to other undefined cells, which either become stem cells or differentiate.  Over the past decade, the technology to use stem cells as personalized therapy has evolved rapidly.  For example, in Multiple Sclerosis (MS) research, the hope is to swap out immune cells that are attacking the patient's own neurons with immune cells, grown from stem cells, that will not attack the neurons.  

On May 13, 2020, MGH released the study taking stem cells from one patient's skin to replace his own dopaminergic neurons lost during his Parkinson's progression.  Dopaminergic neurons produce the majority of the body's dopamine. Parkinson's is associated with tremor and a decline in fine motor skills because the nerve cells do not have enough dopamine to transmit signals between the muscles and the brain.  This study differs from other stem cell research because stem cells typically originate from a bank of stem cells, not the patient's own body.  Though cell banks have greater control over what characteristics the cells have, the patient's body often rejects the transplant.

So far, the 69-year-old patient has responded well to the stem cell transplant.  His body accepted the stem cells, which have reproduced and matured into dopaminergic neurons. Researchers associated with the study say the results are encouraging but emphasize that it was only a single patient test.

The National Institute of Health, McLean Hospital, and MGH, primarily funded the study, but the patient at the center of the study also contributed to the funding.  The researchers worked with the MGH Institutional Review Board to clear all ethical hurdles. 

 

Sources: Schweitzer et. al., ScienceDaily, Mayo Clinic, Harvard Stem Cell Institute

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
DEC 29, 2020
Cannabis Sciences
What Happens When You Combine Cannabis with Psychedelics?
DEC 29, 2020
What Happens When You Combine Cannabis with Psychedelics?
Despite the growing popularity of cannabis and psychedelics, there is a shortage of research on how the two interact. Be ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
JAN 27, 2021
Drug Discovery & Development
Researchers Discover How LSD Encourages Prosocial Behavior
JAN 27, 2021
Researchers Discover How LSD Encourages Prosocial Behavior
Researchers from McGill University have discovered one of the possible mechanisms by which lysergic acid diethylamide (L ...
JAN 28, 2021
Cell & Molecular Biology
Gene Variants Affecting an Ion Channel Alter Parkinson's Disease Risk
JAN 28, 2021
Gene Variants Affecting an Ion Channel Alter Parkinson's Disease Risk
These variants can raise, or lower the risk of the disease, and now researchers have learned how they work.
MAR 09, 2021
Cannabis Sciences
Cannabis Alleviates Neuropathic Pain from Chemotherapy
MAR 09, 2021
Cannabis Alleviates Neuropathic Pain from Chemotherapy
Neuropathic pain from oxaliplatin-based chemotherapy regimens occurs in up to 90% of patients, and continued exposure to ...
MAR 18, 2021
Neuroscience
Pregnancy Alters the Stress Response in Surprising Ways
MAR 18, 2021
Pregnancy Alters the Stress Response in Surprising Ways
Researchers from Ohio State University have found that the stress response works in unexpected ways in pregnant mice. Th ...
Loading Comments...